Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
This study evaluated the safety and effectiveness of Pimavanserin for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Buenos Aires
Comparison of Efficacy and Safety of Transcranial Alternating Current Stimulation vs Transcranial Direct Current Stimulation on Psychopathology Measures and Neurocognition in Chronic Schizophrenia: A Randomized Double-blind Controlled Trial
Current recruitment status is unconfirmed.
In BhubaneswarA Multi-Center, Randomized, Double-Blind Study, Comparing With Risperidone, to Evaluate the Efficacy and Safety of Aripiprazole in the Treatment of Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including GuangzhouThis study evaluated the effectiveness of Cognitive Remediation for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Granada Hills
Efficacy of "Integrated Social Cognitive and Behavioral Skills Therapy" (ISST) in Improving Functional Outcome in Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including AlzeyThis study has finished and is no longer accepting participants.
Multiple locations, including New HavenEfficacy of Transcranial Alternating Current Stimulation (tACS) as an Add-on Treatment for Auditory Hallucinations in Refractory Schizophrenia: A Randomized, Double-blind, Sham-controlled Trial
This study has finished and is no longer accepting participants.
In TianjinSocial Cognition Individualized Activities Lab (SoCIAL) for the Training of Social Cognition and Narrative Enhancement in Patients With Schizophrenia: A Randomized Controlled Study to Assess Efficacy and Generalization to Real-life Functioning
This study has finished and is no longer accepting participants.
In NaplesPhase II, Double Blind, Randomized, Placebo Controlled, Parallel Group, Trial to Explore Efficacy, Safety and Pharmacokinetics of CPL500036 (PDE10A Inhibitor) in Patients With an Acute Exacerbation of Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including BudapestResearchers are comparing AVP-786 and placebo to find out how the approaches affect psychotic symptoms in people with schizophrenia.
This study ended early.
Multiple locations, including Little RockThis study evaluated the safety and effectiveness of NBI-1117568 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8189 in Healthy Volunteers and in Schizophrenia Patients
This study has finished and is no longer accepting participants.
Location not clearly listedWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.